Completion rates of intraperitoneal chemotherapy for stage III epithelial ovarian cancer in a community integrated health care system

被引：0
|
作者：
Lazo, I. [1 ]
White, K. [1 ]
Tucker, L. [2 ]
Zaritsky, E. [1 ]
Han, L. [1 ]
Ciaravino, G. [1 ]
机构：
[1] Kaiser Permanente, Oakland Med Ctr, Dept Obstet & Gynecol, Oakland, CA USA
[2] Kaiser Permanente, Div Res, Oakland, CA USA
来源：
GYNECOLOGIC ONCOLOGY | 2015年 / 139卷 / 01期
关键词：
D O I：
10.1016/j.ygyno.2015.07.073
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：200 / 200
页数：1
相关论文
共 50 条
  • [31] Completion of Adjuvant Chemotherapy and Use of Health Services for Older Women With Epithelial Ovarian Cancer
    Fairfield, Kathleen M.
    Murray, Kimberly
    Lucas, F. Lee
    Wierman, Heidi R.
    Earle, Craig C.
    Trimble, Edward L.
    Small, Laurie
    Warren, Joan L.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (29) : 3921 - 3926
  • [32] NIPEC with Single-Dose Intraperitoneal Cisplatin and Paclitaxel in Stage III Epithelial Ovarian Cancer
    Saldanha, Elroy
    Desai, Sanjay M.
    Patel, Dhruv G.
    Dhakad, Vinod
    Joseph, Bonny
    Ghosh, Sandeep
    Prakash, Varun
    Deepti, Harsha
    Monteiro, Ashma
    SOUTH ASIAN JOURNAL OF CANCER, 2023, 12 (01) : 74 - 80
  • [33] Intraperitoneal cisplatin-based chemotherapy vs. intravenous cisplatin-based chemotherapy for stage III optimally cytoreduced epithelial ovarian cancer
    Yen, MS
    Juang, CM
    Lai, CR
    Chao, GC
    Ng, HT
    Yuan, CC
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2001, 72 (01) : 55 - 60
  • [34] IS INTRAPERITONEAL CHEMOTHERAPY IN THE MANAGEMENT OF RECURRENT EPITHELIAL OVARIAN CANCER FEASIBLE?
    Park, S.
    Nguyen, T.
    Johns, A.
    Adetuyi, O.
    Lin, P.
    Hakim, A.
    Dellinger, T.
    Leong, L.
    Cristea, M.
    Morgan, R.
    Wakabayashi, M.
    Han, E.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2014, 24 (09) : 319 - 319
  • [35] Intraperitoneal Chemotherapy for Epithelial Ovarian Cancer – Single Center Experience
    Rajshekhar C. Jaka
    S. P. Somashekhar
    Shabber S. Zaveri
    Zahoor Ahmed
    K. R. Ashwin
    Indian Journal of Surgical Oncology, 2012, 3 (3) : 262 - 266
  • [36] Hyperthermic Intraperitoneal Chemotherapy for the Treatment of Epithelial Ovarian Cancer Comment
    Wethington, Stephanie L.
    Armstrong, Deborah K.
    Johnston, Fabian M.
    JAMA SURGERY, 2022, 157 (05) : 383 - 383
  • [37] Pros and Cons of Intraperitoneal Chemotherapy in the Treatment of Epithelial Ovarian Cancer
    Zeimet, Alain G.
    Reimer, Daniel
    Radl, Alice C.
    Reinthaller, Alexander
    Schauer, Christian
    Petru, Edgar
    Concin, Nicole
    Braun, Stephan
    Marth, Christian
    ANTICANCER RESEARCH, 2009, 29 (07) : 2803 - 2808
  • [38] Intraperitoneal chemotherapy for the initial management of primary epithelial ovarian cancer
    Jaaback, K
    Johnson, N
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2006, (01):
  • [39] Intraperitoneal chemotherapy for advanced epithelial ovarian cancer: a Canadian perspective
    Alhayki, M.
    Hopkins, L.
    Le, T.
    Fung, M. Fung Kee
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2006, 16 (05) : 1761 - 1765
  • [40] Intraperitoneal carboplatin-based chemotherapy for epithelial ovarian cancer
    Fujiwara, K
    Markman, M
    Morgan, M
    Coleman, RL
    GYNECOLOGIC ONCOLOGY, 2005, 97 (01) : 10 - 15
12345